The report "Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) - Global Forecast to 2026" The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from an estimated USD 2.8 billion in 2021, at an 8.2% CAGR.The increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics, increasing R&D funding, increasing awareness on the early detection of infectious diseases, and the increasing use of POC diagnostic tests drives growth in the point-of-care molecular diagnostics market. Emerging economies in Asia Pacific region are providing lucrative opportunities for the players operating in the point-of-care molecular diagnostics market.



